FLOMAX® Versus HYTRIN® in Patients With the Signs and Symptoms of Benign Prostatic Hyperplasia

NCT02244255 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1993

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostatic Hyperplasia

Interventions

DRUG: FLOMAX® capsules
DRUG: Ascending doses of HYTRIN® capsules

Sponsor

Boehringer Ingelheim